Antithrombotic agents in the treatment of severe sepsis

Author： Shadid Hazar   Aziz Salim   Ahmad Sarfraz   Fareed Jawed   Hoppensteadt Debra   Messmore Harry   Wehrmacher William   Tobu Mahmut   Iqbal Omer  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.7, Iss.1, 2002-05, pp. : 111-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antithrombotic agents

By Uzan A.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 189-208

Informa Healthcare

Access to resources Recommend Favorite

An update on recommendations for the treatment of severe sepsis and septic shock has been released

By  

Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Safety of drotrecogin alfa (activated) in the treatment of patients with severe sepsis

By McCoy Christopher  

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 625-637

Informa Healthcare

Access to resources Recommend Favorite

An update on recommendations for the treatment of severe sepsis and septic shock has been released

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 546, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Granulocyte Colony-stimulating Factor as the Expecting Sword for the Treatment of Severe Sepsis

By  

Current Pharmaceutical Design, Vol. 9, Iss. 14, 2003-05 ,pp. : 1115-1120

Bentham Science Publishers

Access to resources Recommend Favorite